CHRISTY ANDERS: Open Payments
NPI 1730774308 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 47 payments from 14 companies in 2025. Trend: 2023 $556 · 2024 $954 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $242 |
| ABBVIE INC. | 5 | $108 |
| Amgen Inc. | 6 | $101 |
| Exact Sciences Corporation | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| Novo Nordisk Inc | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| Lilly USA, LLC | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $35 |
Products named: AIRSUPRA, FARXIGA, Kerendia, OTEZLA, UBRELVY, Cologuard Collection Kit, BREZTRI, CAPLYTA.
Industry payments across AR — which companies pay providers there.
